MJRIC
Mogy Joel R Investment Counsel Portfolio holdings
AUM
$1.73B
This Quarter Return
+0.83%
1 Year Return
+20.32%
3 Year Return
+125.21%
5 Year Return
+189.43%
10 Year Return
+523.77%
AUM
$540M
AUM Growth
+$540M
(+0.14%)
Cap. Flow
+$395K
Cap. Flow
% of AUM
0.07%
Top 10 Holdings %
Top 10 Hldgs %
33.49%
Holding
126
New
3
Increased
36
Reduced
33
Closed
3
Top Buys
| 1 |
Intuit
INTU
|
$761K |
| 2 |
Meta Platforms (Facebook)
META
|
$704K |
| 3 |
Amazon
AMZN
|
$479K |
| 4 |
Home Depot
HD
|
$436K |
| 5 |
Nike
NKE
|
$413K |
Top Sells
| 1 |
Union Pacific
UNP
|
$1.45M |
| 2 |
BBBY
Bed Bath & Beyond Inc
BBBY
|
$1.19M |
| 3 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
$587K |
| 4 |
Schlumberger
SLB
|
$372K |
| 5 |
Mondelez International
MDLZ
|
$264K |
Sector Composition
| 1 | Technology | 19% |
| 2 | Healthcare | 17.51% |
| 3 | Communication Services | 13.18% |
| 4 | Consumer Discretionary | 12.75% |
| 5 | Consumer Staples | 11.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LUX
26
DELISTED
Luxottica Group
LUX
| $8.16M | 1.51% |
166,910
-3,115
| -2% | -$152K |
|
|
BBBY
27
DELISTED
Bed Bath & Beyond Inc
BBBY
| $7.62M | 1.41% |
176,209
-27,450
| -13% | -$1.19M |
|
28
Henry Schein
HSIC
$8.44B
| $6.83M | 1.27% |
38,625
-45
| -0.1% | -$7.96K |
|
|
29
Nike
NKE
$114B
| $6.4M | 1.19% |
115,924
+7,478
| +7% | +$413K |
|
|
FNGN
30
DELISTED
Financial Engines, Inc.
FNGN
| $6.34M | 1.17% |
245,174
+7,340
| +3% | +$190K |
|
31
GE Aerospace
GE
$292B
| $6.18M | 1.14% |
196,141
+1,610
| +0.8% | +$50.7K |
|
|
32
Meta Platforms (Facebook)
META
$1.86T
| $6.13M | 1.14% |
53,655
+6,156
| +13% | +$704K |
|
33
Gilead Sciences
GILD
$140B
| $5.89M | 1.09% |
70,655
-2,695
| -4% | -$225K |
|
|
34
Union Pacific
UNP
$133B
| $5.71M | 1.06% |
65,438
-16,650
| -20% | -$1.45M |
|
35
Philip Morris
PM
$260B
| $5.5M | 1.02% |
54,025
+400
| +0.7% | +$40.7K |
|
|
AGN
36
DELISTED
Allergan plc
AGN
| $5.18M | 0.96% |
22,418
-22
| -0.1% | -$5.08K |
|
37
Pfizer
PFE
$141B
| $4.99M | 0.92% |
141,804
+2,675
| +2% | +$94.2K |
|
38
Altria Group
MO
$113B
| $4.92M | 0.91% |
71,285
-200
| -0.3% | -$13.8K |
|
39
Idexx Laboratories
IDXX
$51.8B
| $4.74M | 0.88% |
51,080
| – | – |
|
40
Simon Property Group
SPG
$59B
| $4.58M | 0.85% |
21,127
| – | – |
|
41
AbbVie
ABBV
$372B
| $4.52M | 0.84% |
73,066
+100
| +0.1% | +$6.19K |
|
42
Intel
INTC
$107B
| $4.06M | 0.75% |
123,731
| – | – |
|
43
T Rowe Price
TROW
$23.6B
| $3.42M | 0.63% |
46,800
-650
| -1% | -$47.4K |
|
44
Chevron
CVX
$324B
| $3.21M | 0.59% |
30,601
-506
| -2% | -$53K |
|
45
Merck
MRK
$210B
| $2.99M | 0.55% |
51,960
| – | – |
|
46
Palo Alto Networks
PANW
$127B
| $2.97M | 0.55% |
24,215
+2,900
| +14% | +$356K |
|
47
IBM
IBM
$227B
| $2.93M | 0.54% |
19,302
-900
| -4% | -$137K |
|
|
48
Mondelez International
MDLZ
$79.5B
| $2.78M | 0.51% |
60,986
-5,800
| -9% | -$264K |
|
49
Intuitive Surgical
ISRG
$170B
| $2.77M | 0.51% |
4,194
+66
| +2% | +$43.7K |
|
50
Abbott
ABT
$231B
| $2.77M | 0.51% |
70,466
| – | – |
|